Contact Us
Drug Search Results
More Filters [+]

AZD-5462

Alternative Names: azd-5462, azd 5462, azd5462
Latest Update: 2024-10-31
Latest Update Note: Clinical Trial Update

Product Description

AZD-5462 is being developed by AstraZeneca for cardiovascular disease indications. (Sourced from: https://clinicaltrials.gov/ct2/results?cond=&term=AZD-5462&cntry=&state=&city=&dist=)

Mechanisms of Action: CDK Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: AstraZeneca
Company Location: CAMBRIDGE X0 CB2 0AA
Company CEO: Pascal Soriot
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for AZD-5462

Countries in Clinic: Bulgaria, Czech Republic, Denmark, Hungary, India, Japan, Netherlands, Poland, Slovakia, Sweden, United States

Active Clinical Trial Count: 8

Highest Development Phases

Phase 2: Heart Failure, Chronic

Phase 1: Breast Cancer|Healthy Volunteers|Heart Failure|Kidney Diseases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
D9090C00008

P2

Unknown Status

Heart Failure, Chronic

2026-09-19

jRCT2051240066

P2

Recruiting

Heart Failure, Chronic

2026-07-29

LUMINARA

P2

Recruiting

Heart Failure, Chronic

2025-11-24

AURORA

P1

Recruiting

Kidney Diseases|Heart Failure

2025-09-08

Recent News Events

Date

Type

Title

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions